

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.26573776 |
| 2 | neutrophil activation involved in immune response (GO:0002283) | 5.16467260 |
| 3 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 4.48270761 |
| 4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.23856543 |
| 5 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.23856543 |
| 6 | respiratory burst (GO:0045730) | 4.11913179 |
| 7 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.06273604 |
| 8 | cellular response to interleukin-15 (GO:0071350) | 3.99889983 |
| 9 | neutrophil activation (GO:0042119) | 3.90244168 |
| 10 | response to interleukin-15 (GO:0070672) | 3.86184091 |
| 11 | response to peptidoglycan (GO:0032494) | 3.82996164 |
| 12 | cytidine metabolic process (GO:0046087) | 3.81628337 |
| 13 | cytidine catabolic process (GO:0006216) | 3.81628337 |
| 14 | cytidine deamination (GO:0009972) | 3.81628337 |
| 15 | immunoglobulin mediated immune response (GO:0016064) | 3.79847499 |
| 16 | negative T cell selection (GO:0043383) | 3.79554562 |
| 17 | granulocyte activation (GO:0036230) | 3.78649057 |
| 18 | leukocyte aggregation (GO:0070486) | 3.78417096 |
| 19 | detection of other organism (GO:0098543) | 3.77067398 |
| 20 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.72934028 |
| 21 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.69705784 |
| 22 | positive thymic T cell selection (GO:0045059) | 3.66420452 |
| 23 | detection of bacterium (GO:0016045) | 3.59550800 |
| 24 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.56883951 |
| 25 | regulation of regulatory T cell differentiation (GO:0045589) | 3.51988752 |
| 26 | negative thymic T cell selection (GO:0045060) | 3.47697227 |
| 27 | cellular extravasation (GO:0045123) | 3.44729076 |
| 28 | regulation of T cell tolerance induction (GO:0002664) | 3.44716635 |
| 29 | modulation by symbiont of host defense response (GO:0052031) | 3.41512464 |
| 30 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.41512464 |
| 31 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.41512464 |
| 32 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.41512464 |
| 33 | modulation by symbiont of host immune response (GO:0052553) | 3.41512464 |
| 34 | positive regulation by symbiont of host defense response (GO:0052509) | 3.41512464 |
| 35 | positive T cell selection (GO:0043368) | 3.41294846 |
| 36 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.40687655 |
| 37 | actin nucleation (GO:0045010) | 3.38165822 |
| 38 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.33119874 |
| 39 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.33119874 |
| 40 | positive regulation of interferon-alpha production (GO:0032727) | 3.32586098 |
| 41 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.31730634 |
| 42 | detection of external biotic stimulus (GO:0098581) | 3.28776135 |
| 43 | NIK/NF-kappaB signaling (GO:0038061) | 3.28623545 |
| 44 | negative regulation of T cell mediated immunity (GO:0002710) | 3.24950516 |
| 45 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.24832562 |
| 46 | positive regulation of antigen processing and presentation (GO:0002579) | 3.24608925 |
| 47 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.24389424 |
| 48 | detection of molecule of bacterial origin (GO:0032490) | 3.21882309 |
| 49 | microglial cell activation (GO:0001774) | 3.21652279 |
| 50 | regulation of tolerance induction (GO:0002643) | 3.19973249 |
| 51 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.19849732 |
| 52 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.18425354 |
| 53 | regulation of interferon-alpha production (GO:0032647) | 3.15249621 |
| 54 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.14902443 |
| 55 | mast cell activation (GO:0045576) | 3.14700068 |
| 56 | response to muramyl dipeptide (GO:0032495) | 3.13796935 |
| 57 | B cell mediated immunity (GO:0019724) | 3.13765128 |
| 58 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.10492068 |
| 59 | natural killer cell mediated immunity (GO:0002228) | 3.10492068 |
| 60 | T cell migration (GO:0072678) | 3.09366565 |
| 61 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.07450141 |
| 62 | T cell selection (GO:0045058) | 3.05140636 |
| 63 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.03098703 |
| 64 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.02580178 |
| 65 | dendritic cell chemotaxis (GO:0002407) | 3.02198677 |
| 66 | regulation of antigen processing and presentation (GO:0002577) | 2.99039499 |
| 67 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.98858153 |
| 68 | cellular response to zinc ion (GO:0071294) | 2.98279106 |
| 69 | DNA deamination (GO:0045006) | 2.97029615 |
| 70 | type I interferon signaling pathway (GO:0060337) | 2.95741260 |
| 71 | cellular response to type I interferon (GO:0071357) | 2.95741260 |
| 72 | response to type I interferon (GO:0034340) | 2.95517090 |
| 73 | leukocyte mediated cytotoxicity (GO:0001909) | 2.95492238 |
| 74 | regulation of B cell differentiation (GO:0045577) | 2.93963145 |
| 75 | myeloid cell activation involved in immune response (GO:0002275) | 2.93734781 |
| 76 | dendritic cell migration (GO:0036336) | 2.93282978 |
| 77 | superoxide anion generation (GO:0042554) | 2.92652583 |
| 78 | negative regulation of phagocytosis (GO:0050765) | 2.91382933 |
| 79 | positive regulation of B cell differentiation (GO:0045579) | 2.90549877 |
| 80 | myeloid dendritic cell activation (GO:0001773) | 2.90455999 |
| 81 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.89664857 |
| 82 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.89191752 |
| 83 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.88981655 |
| 84 | T cell costimulation (GO:0031295) | 2.87911309 |
| 85 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.87345458 |
| 86 | detection of biotic stimulus (GO:0009595) | 2.85623041 |
| 87 | thymic T cell selection (GO:0045061) | 2.85395036 |
| 88 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.85313759 |
| 89 | positive regulation of tolerance induction (GO:0002645) | 2.84878526 |
| 90 | sequestering of actin monomers (GO:0042989) | 2.84867994 |
| 91 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.84729886 |
| 92 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.84451926 |
| 93 | lymphocyte costimulation (GO:0031294) | 2.84009977 |
| 94 | macrophage activation (GO:0042116) | 2.83773459 |
| 95 | cellular defense response (GO:0006968) | 2.83620160 |
| 96 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.82563260 |
| 97 | positive regulation of mast cell activation (GO:0033005) | 2.82260840 |
| 98 | reactive oxygen species biosynthetic process (GO:1903409) | 2.80580472 |
| 99 | interferon-gamma production (GO:0032609) | 2.78598198 |
| 100 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.78035058 |
| 101 | positive regulation of mast cell degranulation (GO:0043306) | 2.78035058 |
| 102 | myeloid dendritic cell differentiation (GO:0043011) | 2.76002499 |
| 103 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.75744489 |
| 104 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.74912643 |
| 105 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.73907469 |
| 106 | cellular response to interferon-beta (GO:0035458) | 2.73432405 |
| 107 | pinocytosis (GO:0006907) | 2.72837242 |
| 108 | regulation of mast cell activation (GO:0033003) | 2.72577376 |
| 109 | macrophage activation involved in immune response (GO:0002281) | 2.72538394 |
| 110 | regulation of mast cell degranulation (GO:0043304) | 2.71389372 |
| 111 | leukocyte cell-cell adhesion (GO:0007159) | 2.67159196 |
| 112 | positive regulation of macrophage differentiation (GO:0045651) | 2.66868995 |
| 113 | neutrophil mediated immunity (GO:0002446) | 2.66668639 |
| 114 | regulation of RIG-I signaling pathway (GO:0039535) | 2.64577222 |
| 115 | negative regulation of interleukin-12 production (GO:0032695) | 2.64205545 |
| 116 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.64084547 |
| 117 | response to interferon-beta (GO:0035456) | 2.63533802 |
| 118 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.62636500 |
| 119 | defense response to protozoan (GO:0042832) | 2.62505081 |
| 120 | response to protozoan (GO:0001562) | 2.60331521 |
| 121 | response to fungus (GO:0009620) | 2.59186915 |
| 122 | ribosomal small subunit assembly (GO:0000028) | 2.58071637 |
| 123 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.57722033 |
| 124 | leukocyte degranulation (GO:0043299) | 2.55986311 |
| 125 | B cell receptor signaling pathway (GO:0050853) | 2.55869872 |
| 126 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.55459364 |
| 127 | negative regulation of cell killing (GO:0031342) | 2.55459364 |
| 128 | positive regulation of lamellipodium assembly (GO:0010592) | 2.55312660 |
| 129 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.55031176 |
| 130 | lymphocyte mediated immunity (GO:0002449) | 2.53120618 |
| 131 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.52592181 |
| 132 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.52240697 |
| 133 | response to host immune response (GO:0052572) | 2.52141134 |
| 134 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.52141134 |
| 135 | dendritic cell differentiation (GO:0097028) | 2.52055310 |
| 136 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.51660047 |
| 137 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.50476534 |
| 138 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.50221484 |
| 139 | positive regulation of interferon-beta production (GO:0032728) | 2.49915306 |
| 140 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.49755514 |
| 141 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.48970454 |
| 142 | regulation of gamma-delta T cell activation (GO:0046643) | 2.47884078 |
| 143 | myeloid leukocyte activation (GO:0002274) | 2.47810697 |
| 144 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.47264013 |
| 145 | tolerance induction (GO:0002507) | 2.46925413 |
| 146 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.46478615 |
| 147 | positive regulation of isotype switching (GO:0045830) | 2.46439227 |
| 148 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.46400890 |
| 149 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.44442080 |
| 150 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.43599972 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.81440221 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.55750473 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.03594878 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.35569945 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.33760656 |
| 6 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.18429493 |
| 7 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.94343965 |
| 8 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.87942716 |
| 9 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.84960513 |
| 10 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.84544532 |
| 11 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.83370987 |
| 12 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.75259902 |
| 13 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.71438555 |
| 14 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.69844266 |
| 15 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.55049505 |
| 16 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.49432128 |
| 17 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.36027658 |
| 18 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.33289816 |
| 19 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.26551776 |
| 20 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.22284790 |
| 21 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.21841052 |
| 22 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.14669960 |
| 23 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.06340323 |
| 24 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.01045887 |
| 25 | MYB_26560356_Chip-Seq_TH2_Human | 2.00986627 |
| 26 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.96603050 |
| 27 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.93779074 |
| 28 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.89707463 |
| 29 | MAF_26560356_Chip-Seq_TH1_Human | 1.88110052 |
| 30 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.85348822 |
| 31 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.82999041 |
| 32 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.81347708 |
| 33 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.80392837 |
| 34 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.77348153 |
| 35 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.75856828 |
| 36 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.75118792 |
| 37 | MYB_26560356_Chip-Seq_TH1_Human | 1.71220289 |
| 38 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.62949371 |
| 39 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.62931102 |
| 40 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.62242569 |
| 41 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.60162880 |
| 42 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.56703691 |
| 43 | MYC_22102868_ChIP-Seq_BL_Human | 1.53980391 |
| 44 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52429145 |
| 45 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49670978 |
| 46 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.46957466 |
| 47 | UTX_26944678_Chip-Seq_JUKART_Human | 1.45503744 |
| 48 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.42639589 |
| 49 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.42374715 |
| 50 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.38639377 |
| 51 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.34474929 |
| 52 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.33236729 |
| 53 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.30700194 |
| 54 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.29360096 |
| 55 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.27742194 |
| 56 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.27070737 |
| 57 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.26142885 |
| 58 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.26072519 |
| 59 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.26067188 |
| 60 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.25524958 |
| 61 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.21848109 |
| 62 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.20228184 |
| 63 | MAF_26560356_Chip-Seq_TH2_Human | 1.19697096 |
| 64 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.18971561 |
| 65 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.16853017 |
| 66 | GATA1_19941826_ChIP-Seq_K562_Human | 1.15702521 |
| 67 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15699684 |
| 68 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.15510467 |
| 69 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.15488045 |
| 70 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.12520071 |
| 71 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.11719904 |
| 72 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.11586398 |
| 73 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.11133439 |
| 74 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11109425 |
| 75 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.10914109 |
| 76 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.09624520 |
| 77 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.08752069 |
| 78 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.08156235 |
| 79 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.07536674 |
| 80 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.07156265 |
| 81 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.06463151 |
| 82 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.05978247 |
| 83 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.05123659 |
| 84 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.02705382 |
| 85 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.01383270 |
| 86 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.99125619 |
| 87 | GATA2_19941826_ChIP-Seq_K562_Human | 0.97984595 |
| 88 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.97370211 |
| 89 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.96699651 |
| 90 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.96360899 |
| 91 | GATA3_26560356_Chip-Seq_TH2_Human | 0.96143048 |
| 92 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.94947059 |
| 93 | GATA1_22025678_ChIP-Seq_K562_Human | 0.94154030 |
| 94 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.93859098 |
| 95 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.93536091 |
| 96 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.92334629 |
| 97 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.90985102 |
| 98 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.88882342 |
| 99 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.88793254 |
| 100 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.88718479 |
| 101 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.88295125 |
| 102 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.87784651 |
| 103 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.87331043 |
| 104 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.86465591 |
| 105 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.85642876 |
| 106 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.85449128 |
| 107 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.84278474 |
| 108 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.84261039 |
| 109 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.83813526 |
| 110 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.83680471 |
| 111 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.83124422 |
| 112 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.82585026 |
| 113 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.82124590 |
| 114 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.81176016 |
| 115 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.80767166 |
| 116 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.80570555 |
| 117 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.77479472 |
| 118 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.77093848 |
| 119 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.73606515 |
| 120 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.71388472 |
| 121 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.70375184 |
| 122 | P300_27268052_Chip-Seq_Bcells_Human | 0.68147601 |
| 123 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.67685034 |
| 124 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.67042261 |
| 125 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.66269270 |
| 126 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.66135745 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.87170369 |
| 2 | MP0003436_decreased_susceptibility_to | 3.46842585 |
| 3 | MP0009785_altered_susceptibility_to | 3.23355508 |
| 4 | MP0002148_abnormal_hypersensitivity_rea | 2.83509195 |
| 5 | MP0000685_abnormal_immune_system | 2.83121566 |
| 6 | MP0005000_abnormal_immune_tolerance | 2.80181549 |
| 7 | MP0002419_abnormal_innate_immunity | 2.70791803 |
| 8 | MP0003724_increased_susceptibility_to | 2.69693951 |
| 9 | MP0005671_abnormal_response_to | 2.66699183 |
| 10 | MP0003303_peritoneal_inflammation | 2.65130888 |
| 11 | MP0005025_abnormal_response_to | 2.64558237 |
| 12 | MP0001790_abnormal_immune_system | 2.55559216 |
| 13 | MP0005387_immune_system_phenotype | 2.55559216 |
| 14 | MP0001800_abnormal_humoral_immune | 2.52202153 |
| 15 | MP0002452_abnormal_antigen_presenting | 2.49807845 |
| 16 | MP0006082_CNS_inflammation | 2.41000486 |
| 17 | MP0002723_abnormal_immune_serum | 2.37408636 |
| 18 | MP0001819_abnormal_immune_cell | 2.28982326 |
| 19 | MP0002420_abnormal_adaptive_immunity | 2.28527810 |
| 20 | MP0002405_respiratory_system_inflammati | 2.07745199 |
| 21 | MP0005058_abnormal_lysosome_morphology | 2.05561177 |
| 22 | MP0002166_altered_tumor_susceptibility | 2.00036495 |
| 23 | MP0001853_heart_inflammation | 1.98867404 |
| 24 | MP0005464_abnormal_platelet_physiology | 1.94081731 |
| 25 | MP0009333_abnormal_splenocyte_physiolog | 1.87813421 |
| 26 | MP0001533_abnormal_skeleton_physiology | 1.87449588 |
| 27 | MP0002006_tumorigenesis | 1.81298286 |
| 28 | MP0003763_abnormal_thymus_physiology | 1.81294385 |
| 29 | MP0002398_abnormal_bone_marrow | 1.81216829 |
| 30 | MP0001845_abnormal_inflammatory_respons | 1.78806918 |
| 31 | MP0000716_abnormal_immune_system | 1.78605829 |
| 32 | MP0004947_skin_inflammation | 1.78064579 |
| 33 | MP0010155_abnormal_intestine_physiology | 1.76511522 |
| 34 | MP0000858_altered_metastatic_potential | 1.74305070 |
| 35 | MP0004510_myositis | 1.70644991 |
| 36 | MP0002396_abnormal_hematopoietic_system | 1.68568684 |
| 37 | MP0001545_abnormal_hematopoietic_system | 1.65283841 |
| 38 | MP0005397_hematopoietic_system_phenotyp | 1.65283841 |
| 39 | MP0000343_altered_response_to | 1.59659119 |
| 40 | MP0003448_altered_tumor_morphology | 1.59396384 |
| 41 | MP0000689_abnormal_spleen_morphology | 1.57664648 |
| 42 | MP0009278_abnormal_bone_marrow | 1.55749215 |
| 43 | MP0002429_abnormal_blood_cell | 1.52308850 |
| 44 | MP0003806_abnormal_nucleotide_metabolis | 1.52139827 |
| 45 | MP0002722_abnormal_immune_system | 1.51836752 |
| 46 | MP0008469_abnormal_protein_level | 1.47090980 |
| 47 | MP0009840_abnormal_foam_cell | 1.45974330 |
| 48 | MP0009764_decreased_sensitivity_to | 1.45670544 |
| 49 | MP0001873_stomach_inflammation | 1.41773351 |
| 50 | MP0003300_gastrointestinal_ulcer | 1.40474655 |
| 51 | MP0003191_abnormal_cellular_cholesterol | 1.38289091 |
| 52 | MP0000490_abnormal_crypts_of | 1.34469541 |
| 53 | MP0010352_gastrointestinal_tract_polyps | 1.34155019 |
| 54 | MP0002138_abnormal_hepatobiliary_system | 1.33096540 |
| 55 | MP0002933_joint_inflammation | 1.32220092 |
| 56 | MP0004381_abnormal_hair_follicle | 1.26531359 |
| 57 | MP0000465_gastrointestinal_hemorrhage | 1.22720644 |
| 58 | MP0004808_abnormal_hematopoietic_stem | 1.20363013 |
| 59 | MP0003186_abnormal_redox_activity | 1.19629937 |
| 60 | MP0002998_abnormal_bone_remodeling | 1.18969925 |
| 61 | MP0003172_abnormal_lysosome_physiology | 1.18565202 |
| 62 | MP0005310_abnormal_salivary_gland | 1.17743918 |
| 63 | MP0003566_abnormal_cell_adhesion | 1.15275432 |
| 64 | MP0003693_abnormal_embryo_hatching | 1.13666090 |
| 65 | MP0003866_abnormal_defecation | 1.11652012 |
| 66 | MP0003828_pulmonary_edema | 1.07749317 |
| 67 | MP0005023_abnormal_wound_healing | 1.07602629 |
| 68 | MP0000604_amyloidosis | 1.06649702 |
| 69 | MP0008004_abnormal_stomach_pH | 1.05510426 |
| 70 | MP0005451_abnormal_body_composition | 1.03744135 |
| 71 | MP0000703_abnormal_thymus_morphology | 1.02761556 |
| 72 | MP0002277_abnormal_respiratory_mucosa | 1.02609332 |
| 73 | MP0004883_abnormal_blood_vessel | 1.02384741 |
| 74 | MP0005174_abnormal_tail_pigmentation | 1.01347628 |
| 75 | MP0001851_eye_inflammation | 1.01042052 |
| 76 | MP0010307_abnormal_tumor_latency | 0.97319153 |
| 77 | MP0003453_abnormal_keratinocyte_physiol | 0.96913766 |
| 78 | MP0005390_skeleton_phenotype | 0.95952553 |
| 79 | MP0008438_abnormal_cutaneous_collagen | 0.95273083 |
| 80 | MP0003045_fibrosis | 0.91440924 |
| 81 | MP0003690_abnormal_glial_cell | 0.90993044 |
| 82 | MP0001958_emphysema | 0.89842259 |
| 83 | MP0002019_abnormal_tumor_incidence | 0.89760334 |
| 84 | MP0005166_decreased_susceptibility_to | 0.89177297 |
| 85 | MP0002254_reproductive_system_inflammat | 0.88921875 |
| 86 | MP0000569_abnormal_digit_pigmentation | 0.87148010 |
| 87 | MP0009763_increased_sensitivity_to | 0.85904805 |
| 88 | MP0003075_altered_response_to | 0.85376465 |
| 89 | MP0002132_abnormal_respiratory_system | 0.85214401 |
| 90 | MP0004782_abnormal_surfactant_physiolog | 0.82553997 |
| 91 | MP0000249_abnormal_blood_vessel | 0.81758778 |
| 92 | MP0005167_abnormal_blood-brain_barrier | 0.80838035 |
| 93 | MP0005075_abnormal_melanosome_morpholog | 0.80592023 |
| 94 | MP0005164_abnormal_response_to | 0.80399735 |
| 95 | MP0003279_aneurysm | 0.79638960 |
| 96 | MP0002136_abnormal_kidney_physiology | 0.77934053 |
| 97 | MP0008260_abnormal_autophagy | 0.77185356 |
| 98 | MP0001542_abnormal_bone_strength | 0.76948528 |
| 99 | MP0003183_abnormal_peptide_metabolism | 0.76699991 |
| 100 | MP0009765_abnormal_xenobiotic_induced | 0.76232290 |
| 101 | MP0006054_spinal_hemorrhage | 0.75395822 |
| 102 | MP0003795_abnormal_bone_structure | 0.73091171 |
| 103 | MP0002877_abnormal_melanocyte_morpholog | 0.72802541 |
| 104 | MP0005076_abnormal_cell_differentiation | 0.69550049 |
| 105 | MP0005165_increased_susceptibility_to | 0.68149676 |
| 106 | MP0003656_abnormal_erythrocyte_physiolo | 0.66976403 |
| 107 | MP0003091_abnormal_cell_migration | 0.63442338 |
| 108 | MP0001663_abnormal_digestive_system | 0.63207515 |
| 109 | MP0001216_abnormal_epidermal_layer | 0.61409457 |
| 110 | MP0001243_abnormal_dermal_layer | 0.60818665 |
| 111 | MP0000371_diluted_coat_color | 0.58284348 |
| 112 | MP0001765_abnormal_ion_homeostasis | 0.57290200 |
| 113 | MP0002009_preneoplasia | 0.57045302 |
| 114 | MP0000015_abnormal_ear_pigmentation | 0.57007933 |
| 115 | MP0002693_abnormal_pancreas_physiology | 0.55593084 |
| 116 | MP0008874_decreased_physiological_sensi | 0.55167958 |
| 117 | MP0005319_abnormal_enzyme/_coenzyme | 0.53925808 |
| 118 | MP0003252_abnormal_bile_duct | 0.52084431 |
| 119 | MP0000609_abnormal_liver_physiology | 0.51300530 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 6.29790816 |
| 2 | Recurrent abscess formation (HP:0002722) | 6.06992173 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 5.40942323 |
| 4 | Abnormality of macrophages (HP:0004311) | 4.61357453 |
| 5 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.41778392 |
| 6 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.41592699 |
| 7 | Myositis (HP:0100614) | 4.33314008 |
| 8 | Vacuolated lymphocytes (HP:0001922) | 4.05134555 |
| 9 | Recurrent fungal infections (HP:0002841) | 3.94685204 |
| 10 | Chronic obstructive pulmonary disease (HP:0006510) | 3.79415363 |
| 11 | Obstructive lung disease (HP:0006536) | 3.79415363 |
| 12 | Mediastinal lymphadenopathy (HP:0100721) | 3.70513545 |
| 13 | Recurrent skin infections (HP:0001581) | 3.61693280 |
| 14 | Orchitis (HP:0100796) | 3.56568293 |
| 15 | Gingivitis (HP:0000230) | 3.23272554 |
| 16 | Cellulitis (HP:0100658) | 3.21677372 |
| 17 | Pustule (HP:0200039) | 3.21580127 |
| 18 | Recurrent viral infections (HP:0004429) | 3.21445253 |
| 19 | Autoimmune thrombocytopenia (HP:0001973) | 3.20245404 |
| 20 | Autoimmune hemolytic anemia (HP:0001890) | 3.18044034 |
| 21 | Petechiae (HP:0000967) | 3.15929798 |
| 22 | Optic neuritis (HP:0100653) | 3.14343611 |
| 23 | Retrobulbar optic neuritis (HP:0100654) | 3.14343611 |
| 24 | Vasculitis (HP:0002633) | 3.08223970 |
| 25 | Stomatitis (HP:0010280) | 3.07863849 |
| 26 | IgM deficiency (HP:0002850) | 2.97271979 |
| 27 | Meningitis (HP:0001287) | 2.96766356 |
| 28 | Chronic otitis media (HP:0000389) | 2.85944012 |
| 29 | Interstitial pulmonary disease (HP:0006530) | 2.85781644 |
| 30 | Chest pain (HP:0100749) | 2.84906144 |
| 31 | Keratoconjunctivitis (HP:0001096) | 2.84899653 |
| 32 | Recurrent cutaneous fungal infections (HP:0011370) | 2.84569468 |
| 33 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.84569468 |
| 34 | Urticaria (HP:0001025) | 2.74168471 |
| 35 | Spontaneous hematomas (HP:0007420) | 2.72137635 |
| 36 | Thrombocytosis (HP:0001894) | 2.72029521 |
| 37 | Increased cerebral lipofuscin (HP:0011813) | 2.70832717 |
| 38 | Systemic lupus erythematosus (HP:0002725) | 2.69598229 |
| 39 | Gangrene (HP:0100758) | 2.62677486 |
| 40 | Pulmonary embolism (HP:0002204) | 2.62203236 |
| 41 | Leukocytosis (HP:0001974) | 2.61848692 |
| 42 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.60931056 |
| 43 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.60912031 |
| 44 | Severe combined immunodeficiency (HP:0004430) | 2.57556524 |
| 45 | Joint swelling (HP:0001386) | 2.55725179 |
| 46 | Abnormality of T cell physiology (HP:0011840) | 2.53465406 |
| 47 | Eosinophilia (HP:0001880) | 2.52558748 |
| 48 | Abnormality of T cells (HP:0002843) | 2.52051908 |
| 49 | Osteomyelitis (HP:0002754) | 2.51759730 |
| 50 | Abnormality of the nasal mucosa (HP:0000433) | 2.50475023 |
| 51 | Abnormality of T cell number (HP:0011839) | 2.49583107 |
| 52 | Pulmonary infiltrates (HP:0002113) | 2.49164907 |
| 53 | Recurrent bronchitis (HP:0002837) | 2.48220300 |
| 54 | Nasal polyposis (HP:0100582) | 2.47830394 |
| 55 | Hypergammaglobulinemia (HP:0010702) | 2.45931969 |
| 56 | Basal ganglia calcification (HP:0002135) | 2.45246794 |
| 57 | Chronic diarrhea (HP:0002028) | 2.45091391 |
| 58 | Increased IgE level (HP:0003212) | 2.43606249 |
| 59 | Axonal loss (HP:0003447) | 2.43002676 |
| 60 | Hemoptysis (HP:0002105) | 2.41931372 |
| 61 | Dysostosis multiplex (HP:0000943) | 2.41267573 |
| 62 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.40975370 |
| 63 | Increased IgM level (HP:0003496) | 2.40288178 |
| 64 | Recurrent pneumonia (HP:0006532) | 2.38103093 |
| 65 | Granulocytopenia (HP:0001913) | 2.37815961 |
| 66 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.37801588 |
| 67 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.37801588 |
| 68 | Abnormality of glycolipid metabolism (HP:0010969) | 2.37801588 |
| 69 | T lymphocytopenia (HP:0005403) | 2.35538697 |
| 70 | Periodontitis (HP:0000704) | 2.34671648 |
| 71 | Hematochezia (HP:0002573) | 2.31451056 |
| 72 | Arterial thrombosis (HP:0004420) | 2.31393441 |
| 73 | Episodic fever (HP:0001954) | 2.29481929 |
| 74 | Inflammation of the large intestine (HP:0002037) | 2.28614716 |
| 75 | Abnormality of the pleura (HP:0002103) | 2.27973473 |
| 76 | Vertebral compression fractures (HP:0002953) | 2.27356134 |
| 77 | Skin ulcer (HP:0200042) | 2.27236769 |
| 78 | Combined immunodeficiency (HP:0005387) | 2.26296721 |
| 79 | Hepatosplenomegaly (HP:0001433) | 2.25718925 |
| 80 | Epistaxis (HP:0000421) | 2.25100015 |
| 81 | Panhypogammaglobulinemia (HP:0003139) | 2.24553282 |
| 82 | Recurrent lower respiratory tract infections (HP:0002783) | 2.24098717 |
| 83 | Gingival bleeding (HP:0000225) | 2.23431932 |
| 84 | Prostate neoplasm (HP:0100787) | 2.22841175 |
| 85 | Abnormal platelet volume (HP:0011876) | 2.21622385 |
| 86 | Abnormality of eosinophils (HP:0001879) | 2.21479662 |
| 87 | Amyloidosis (HP:0011034) | 2.19419346 |
| 88 | Prolonged bleeding time (HP:0003010) | 2.19077456 |
| 89 | Glomerulopathy (HP:0100820) | 2.18306780 |
| 90 | Gastrointestinal inflammation (HP:0004386) | 2.17515760 |
| 91 | Abnormality of the prostate (HP:0008775) | 2.17297009 |
| 92 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.16074195 |
| 93 | Osteolytic defects of the hand bones (HP:0009699) | 2.16074195 |
| 94 | Purpura (HP:0000979) | 2.14566735 |
| 95 | Polyneuropathy (HP:0001271) | 2.12476718 |
| 96 | Myocardial infarction (HP:0001658) | 2.12017554 |
| 97 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.11989646 |
| 98 | Lymphopenia (HP:0001888) | 2.11602126 |
| 99 | Poor head control (HP:0002421) | 2.10114662 |
| 100 | Cheilitis (HP:0100825) | 2.09241072 |
| 101 | Encephalitis (HP:0002383) | 2.09182228 |
| 102 | Abnormality of iron homeostasis (HP:0011031) | 2.08310691 |
| 103 | Keratoconjunctivitis sicca (HP:0001097) | 2.06155322 |
| 104 | Vertigo (HP:0002321) | 2.04415127 |
| 105 | Acute hepatic failure (HP:0006554) | 2.03274131 |
| 106 | Gastrointestinal infarctions (HP:0005244) | 2.02937168 |
| 107 | Agnosia (HP:0010524) | 2.02594598 |
| 108 | Skin rash (HP:0000988) | 2.02516210 |
| 109 | Pulmonary fibrosis (HP:0002206) | 2.01760961 |
| 110 | Peritonitis (HP:0002586) | 2.01595007 |
| 111 | Thyroiditis (HP:0100646) | 2.01442042 |
| 112 | Increased serum ferritin (HP:0003281) | 2.00943420 |
| 113 | Anorexia (HP:0002039) | 2.00742347 |
| 114 | Colitis (HP:0002583) | 2.00096366 |
| 115 | Abnormality of the pericardium (HP:0001697) | 1.99840375 |
| 116 | Arthralgia (HP:0002829) | 1.99459560 |
| 117 | Abnormality of B cell number (HP:0010975) | 1.97057836 |
| 118 | Hypochromic anemia (HP:0001931) | 1.96844875 |
| 119 | Sepsis (HP:0100806) | 1.96822569 |
| 120 | Gastrointestinal stroma tumor (HP:0100723) | 1.95802072 |
| 121 | IgG deficiency (HP:0004315) | 1.95491732 |
| 122 | Mucopolysacchariduria (HP:0008155) | 1.95332823 |
| 123 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.95332823 |
| 124 | Abnormal platelet function (HP:0011869) | 1.94818341 |
| 125 | Impaired platelet aggregation (HP:0003540) | 1.94818341 |
| 126 | Agammaglobulinemia (HP:0004432) | 1.94222316 |
| 127 | Menorrhagia (HP:0000132) | 1.93143467 |
| 128 | Reduced antithrombin III activity (HP:0001976) | 1.92835665 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BLK | 3.65795731 |
| 2 | MAP4K1 | 3.13849141 |
| 3 | MAP3K14 | 2.97412365 |
| 4 | IRAK4 | 2.90169572 |
| 5 | TBK1 | 2.76587232 |
| 6 | NME2 | 2.72039705 |
| 7 | TYK2 | 2.64838577 |
| 8 | PIM2 | 2.63525523 |
| 9 | IRAK3 | 2.47144062 |
| 10 | TXK | 2.29121912 |
| 11 | JAK3 | 2.19483885 |
| 12 | ERN1 | 2.12198687 |
| 13 | IKBKE | 2.08229094 |
| 14 | KIT | 2.07630391 |
| 15 | ZAP70 | 2.07190244 |
| 16 | IKBKB | 1.99960961 |
| 17 | TEC | 1.98187307 |
| 18 | BMPR2 | 1.93089650 |
| 19 | STK10 | 1.79765488 |
| 20 | TESK2 | 1.74802496 |
| 21 | NEK9 | 1.74599181 |
| 22 | BTK | 1.72360613 |
| 23 | KDR | 1.66437129 |
| 24 | RIPK4 | 1.66298706 |
| 25 | CSK | 1.64818324 |
| 26 | JAK1 | 1.55737917 |
| 27 | MST4 | 1.54420776 |
| 28 | RPS6KA4 | 1.51308991 |
| 29 | PIM1 | 1.47920816 |
| 30 | TNK2 | 1.46577002 |
| 31 | MAP2K3 | 1.43149929 |
| 32 | TGFBR2 | 1.42298756 |
| 33 | LRRK2 | 1.40571339 |
| 34 | SYK | 1.31677267 |
| 35 | EPHB1 | 1.31359964 |
| 36 | CSF1R | 1.30656297 |
| 37 | ITK | 1.29313859 |
| 38 | GRK7 | 1.26284153 |
| 39 | HCK | 1.16260247 |
| 40 | LCK | 1.13095115 |
| 41 | PBK | 1.10690729 |
| 42 | GRK6 | 1.10598937 |
| 43 | MAP3K11 | 1.07146285 |
| 44 | TESK1 | 1.06149565 |
| 45 | TAOK3 | 1.05243281 |
| 46 | TRPM7 | 1.03853294 |
| 47 | LYN | 1.01948314 |
| 48 | CHUK | 1.01244245 |
| 49 | PRPF4B | 1.00891629 |
| 50 | MATK | 0.99590133 |
| 51 | SIK3 | 0.98076948 |
| 52 | NLK | 0.95250140 |
| 53 | FGFR4 | 0.94913879 |
| 54 | PRKCQ | 0.90021445 |
| 55 | EIF2AK1 | 0.85605806 |
| 56 | EPHA3 | 0.84715264 |
| 57 | MAP3K3 | 0.84425702 |
| 58 | MAP3K1 | 0.84144526 |
| 59 | MAPKAPK3 | 0.83952024 |
| 60 | MAP3K13 | 0.83808174 |
| 61 | FLT3 | 0.81298575 |
| 62 | EIF2AK3 | 0.80919029 |
| 63 | PDK1 | 0.80536251 |
| 64 | TAOK1 | 0.80243119 |
| 65 | MARK3 | 0.78916826 |
| 66 | TAOK2 | 0.77624383 |
| 67 | STK4 | 0.77476514 |
| 68 | TLK1 | 0.74178341 |
| 69 | CLK1 | 0.73823959 |
| 70 | FES | 0.73129333 |
| 71 | EIF2AK2 | 0.72164571 |
| 72 | JAK2 | 0.70635122 |
| 73 | FGFR3 | 0.70299380 |
| 74 | GRK5 | 0.70030286 |
| 75 | PAK4 | 0.69861131 |
| 76 | SCYL2 | 0.69468360 |
| 77 | FYN | 0.66579863 |
| 78 | TRIB3 | 0.65791226 |
| 79 | ABL2 | 0.65321238 |
| 80 | MAP3K12 | 0.64175869 |
| 81 | CAMKK2 | 0.63930593 |
| 82 | MAPKAPK2 | 0.63705874 |
| 83 | PTK2B | 0.61267889 |
| 84 | IRAK1 | 0.61247969 |
| 85 | MAP3K8 | 0.60139144 |
| 86 | ACVR1B | 0.59478686 |
| 87 | ARAF | 0.57247136 |
| 88 | MYLK | 0.55670912 |
| 89 | STK16 | 0.54616203 |
| 90 | PRKCD | 0.53476171 |
| 91 | PDPK1 | 0.51139983 |
| 92 | PRKG2 | 0.50225955 |
| 93 | BUB1 | 0.49143614 |
| 94 | EPHA2 | 0.48885202 |
| 95 | RPS6KB2 | 0.47638592 |
| 96 | RPS6KA6 | 0.46639435 |
| 97 | PIK3CG | 0.46597167 |
| 98 | ABL1 | 0.46476511 |
| 99 | MOS | 0.46420351 |
| 100 | MAP2K6 | 0.46419411 |
| 101 | FGR | 0.44137815 |
| 102 | MAP3K10 | 0.43687785 |
| 103 | STK24 | 0.43389635 |
| 104 | RPS6KA5 | 0.41450383 |
| 105 | ADRBK2 | 0.40994954 |
| 106 | KSR2 | 0.40575022 |
| 107 | MAP2K2 | 0.40471917 |
| 108 | NEK2 | 0.39324586 |
| 109 | BMX | 0.37894139 |
| 110 | TTN | 0.37737442 |
| 111 | MAPK12 | 0.37145371 |
| 112 | IRAK2 | 0.37078460 |
| 113 | MAP3K5 | 0.35524154 |
| 114 | RPS6KC1 | 0.34195698 |
| 115 | RPS6KL1 | 0.34195698 |
| 116 | PRKD2 | 0.33682373 |
| 117 | IGF1R | 0.33634190 |
| 118 | TGFBR1 | 0.33615096 |
| 119 | PRKD1 | 0.33267663 |
| 120 | CDK4 | 0.32533486 |
| 121 | MAPK4 | 0.32214986 |
| 122 | CDK6 | 0.31791371 |
| 123 | YES1 | 0.31270433 |
| 124 | LIMK1 | 0.30874966 |
| 125 | HIPK2 | 0.30327180 |
| 126 | EGFR | 0.30094674 |
| 127 | DAPK1 | 0.28980228 |
| 128 | MAP3K2 | 0.27960993 |
| 129 | FER | 0.27686607 |
| 130 | DAPK2 | 0.24645794 |
| 131 | INSR | 0.24396709 |
| 132 | PAK1 | 0.20677963 |
| 133 | MAPK7 | 0.20491164 |
| 134 | ADRBK1 | 0.20304016 |
| 135 | NUAK1 | 0.18597541 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 2.94650951 |
| 2 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.43486054 |
| 3 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.31287649 |
| 4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.25430676 |
| 5 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.22569781 |
| 6 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.16658839 |
| 7 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.11844953 |
| 8 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.08977777 |
| 9 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.08539540 |
| 10 | Measles_Homo sapiens_hsa05162 | 2.07971105 |
| 11 | Legionellosis_Homo sapiens_hsa05134 | 2.02750028 |
| 12 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.01540295 |
| 13 | Ribosome_Homo sapiens_hsa03010 | 1.96654302 |
| 14 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.95198672 |
| 15 | Other glycan degradation_Homo sapiens_hsa00511 | 1.94186125 |
| 16 | Allograft rejection_Homo sapiens_hsa05330 | 1.91952071 |
| 17 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.84429754 |
| 18 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.82487715 |
| 19 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.81778190 |
| 20 | Pertussis_Homo sapiens_hsa05133 | 1.76167406 |
| 21 | Malaria_Homo sapiens_hsa05144 | 1.73741078 |
| 22 | Proteasome_Homo sapiens_hsa03050 | 1.69550574 |
| 23 | Shigellosis_Homo sapiens_hsa05131 | 1.66885564 |
| 24 | Tuberculosis_Homo sapiens_hsa05152 | 1.65794029 |
| 25 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.62895988 |
| 26 | Lysosome_Homo sapiens_hsa04142 | 1.61945323 |
| 27 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.60051925 |
| 28 | Apoptosis_Homo sapiens_hsa04210 | 1.55706901 |
| 29 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.52086462 |
| 30 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.49396366 |
| 31 | Asthma_Homo sapiens_hsa05310 | 1.48610360 |
| 32 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.47451495 |
| 33 | Influenza A_Homo sapiens_hsa05164 | 1.43660935 |
| 34 | Salmonella infection_Homo sapiens_hsa05132 | 1.42864492 |
| 35 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.42720525 |
| 36 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.39646874 |
| 37 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.36167857 |
| 38 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.34197508 |
| 39 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.32988095 |
| 40 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.30761734 |
| 41 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.25987133 |
| 42 | DNA replication_Homo sapiens_hsa03030 | 1.24798848 |
| 43 | Phagosome_Homo sapiens_hsa04145 | 1.22060813 |
| 44 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.16198634 |
| 45 | Viral myocarditis_Homo sapiens_hsa05416 | 1.14835668 |
| 46 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.10264678 |
| 47 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.07641985 |
| 48 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.07176439 |
| 49 | Hepatitis B_Homo sapiens_hsa05161 | 1.04996038 |
| 50 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.04139416 |
| 51 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.03835967 |
| 52 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.01621046 |
| 53 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.00287567 |
| 54 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.99966946 |
| 55 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.99796106 |
| 56 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.99622567 |
| 57 | Base excision repair_Homo sapiens_hsa03410 | 0.91748946 |
| 58 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.90388697 |
| 59 | Hepatitis C_Homo sapiens_hsa05160 | 0.87809987 |
| 60 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.84690103 |
| 61 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.83098193 |
| 62 | Platelet activation_Homo sapiens_hsa04611 | 0.70627909 |
| 63 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.69909434 |
| 64 | Homologous recombination_Homo sapiens_hsa03440 | 0.69394197 |
| 65 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.68558356 |
| 66 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.67710703 |
| 67 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.67549273 |
| 68 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.67063060 |
| 69 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.66317167 |
| 70 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.65574704 |
| 71 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.64949873 |
| 72 | Mismatch repair_Homo sapiens_hsa03430 | 0.61552359 |
| 73 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.60170567 |
| 74 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.59350549 |
| 75 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.57394071 |
| 76 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.56987407 |
| 77 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.56667416 |
| 78 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.55424365 |
| 79 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.52675102 |
| 80 | HTLV-I infection_Homo sapiens_hsa05166 | 0.51481500 |
| 81 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.51183439 |
| 82 | Amoebiasis_Homo sapiens_hsa05146 | 0.49953939 |
| 83 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.48519547 |
| 84 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.48060270 |
| 85 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.47992754 |
| 86 | Endocytosis_Homo sapiens_hsa04144 | 0.46987041 |
| 87 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.45275308 |
| 88 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.43727588 |
| 89 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.42557589 |
| 90 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.40755443 |
| 91 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.36964185 |
| 92 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.36764768 |
| 93 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.35832028 |
| 94 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.35758027 |
| 95 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.35718096 |
| 96 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.35580472 |
| 97 | Sulfur relay system_Homo sapiens_hsa04122 | 0.35235532 |
| 98 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.34485395 |
| 99 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.34460980 |
| 100 | Protein export_Homo sapiens_hsa03060 | 0.33571534 |
| 101 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.33093968 |
| 102 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.32831865 |
| 103 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.32480198 |
| 104 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.32014884 |
| 105 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.28167130 |
| 106 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.27283700 |
| 107 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.22757605 |
| 108 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.22757182 |
| 109 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.18350177 |
| 110 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.18310862 |
| 111 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.16786247 |
| 112 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.14537625 |
| 113 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.12250352 |
| 114 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.10934210 |
| 115 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.10677482 |
| 116 | Insulin resistance_Homo sapiens_hsa04931 | 0.09022446 |
| 117 | Galactose metabolism_Homo sapiens_hsa00052 | 0.08676110 |

